Suppr超能文献

肌萎缩侧索硬化症:促甲状腺激素释放激素的双盲交叉试验

Amyotrophic lateral sclerosis: a double-blind crossover trial of thyrotropin-releasing hormone.

作者信息

Imoto K, Saida K, Iwamura K, Saida T, Nishitani H

出版信息

J Neurol Neurosurg Psychiatry. 1984 Dec;47(12):1332-4. doi: 10.1136/jnnp.47.12.1332.

Abstract

A double-blind crossover trial was conducted of thyrotropin releasing hormone treatment in six patients with amyotrophic lateral sclerosis. Patients received 4 mg of thyrotropin releasing hormone intramuscularly daily during the two-week treatment period. Although three patients reported subjective improvement, objective evaluation failed to demonstrate therapeutic effectiveness of thyrotropin releasing hormone in this dosage.

摘要

对6例肌萎缩侧索硬化症患者进行了促甲状腺激素释放激素治疗的双盲交叉试验。在为期两周的治疗期间,患者每天接受4毫克促甲状腺激素释放激素肌肉注射。尽管有3例患者报告主观症状有所改善,但客观评估未能证明该剂量的促甲状腺激素释放激素具有治疗效果。

相似文献

引用本文的文献

3
Treatment for familial amyotrophic lateral sclerosis/motor neuron disease.家族性肌萎缩侧索硬化症/运动神经元病的治疗
Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD006153. doi: 10.1002/14651858.CD006153.pub2.
4
Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症
Curr Treat Options Neurol. 2000 Jan;2(1):13-22. doi: 10.1007/s11940-000-0020-3.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验